Administration of anti-receptor activator of nuclear...

Administration of anti-receptor activator of nuclear factor-kappa B ligand (RANKL) antibody for the treatment of osteoporosis was associated with amelioration of hepatitis in a female patient with growth hormone deficiency: a case report

Takeno, Ayumu, Yamamoto, Masahiro, Notsu, Masakazu, Sugimoto, Toshitsugu
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
16
Language:
english
Journal:
BMC Endocrine Disorders
DOI:
10.1186/s12902-016-0148-0
Date:
December, 2016
File:
PDF, 770 KB
english, 2016
Conversion to is in progress
Conversion to is failed